Oct 28, 2026 earnings call — Talkspace integration and hospital ramp progress
UHS reported adjusted EPS of $5.22, down 8%, and adjusted EBITDA less NCI of $625 million.
Revenue $4.7B (est $4.7B) · EPS $5.22 (est $5.19)
Key quotes
"The additional 177 beds added during the second quarter are expected to continue ramping through year-end."
"Second, behavioral health, we completed the Talkspace acquisition on August 17 and began executing the integration plan."
"Third, at Laurel Ridge, our San Antonio team continues to work productively with regulatory authorities and the local community towards recertification, which we currently expect during 2027."
Analyst Q&A 13
2027 headwinds and service mix
Q (AJ Rice · UBS): The analyst asked for early puts and takes for 2027, specifically DPP and supplemental payment headwinds and any public exchange headwind. He also asked what medical service lines are strong and whether surgical softness is due to exchange disenrollment or the economy.
A: Management said they will give full 2027 guidance in February but pointed to several swing factors now. They said facilities losing money in 2026 (including Laurel Ridge San Antonio and acute de novos) may recover in 2027, but regulatory changes are headwinds. They estimated a 2027 Medicaid supplemental headwind of approximately $175 million-$200 million, an annualized exchange headwind of $15 million, and noted medical procedures are shifting into alternative outpatient settings while cardiology, neurology, and urology are strong.
"As it relates to Medicaid supplemental payments, we estimate the 2027 headwind will be approximately $175 million-$200 million." — Steve Filton (CFO)
Why two hospitals lagged ramp
Q (Ann Hynes · Mizuho): The analyst asked what is driving the slower-than-expected ramp at the two acute facilities and whether the issues are structural in each market.
A: Management said Cedar Hill opened with busy emergency-room activity but surgical and procedural schedules lag because of a lack of physician infrastructure in that part of Washington, D.C., and building physician practices takes time. For Palm Beach Gardens, they said opening in early summer after construction delays led to a slower start, but volumes are improving monthly and should accelerate in the busy season.
"I think the reason for that primarily is a lack of physician infrastructure in that part of the Washington, D.C., market." — Steve Filton (CFO)
Losses at underperforming facilities
Q (Justin Lake · Wolfe): The analyst asked to break down the $80 million-$100 million of losses between the three facilities and to know Laurel Ridge's prior operating profits and timeline to come back online.
A: Management said they expect to be back online sooner rather than later in 2027 but could not give an exact date while regulatory work continues. They disclosed Laurel Ridge's prior-year pre-tax income was in the $20 million-$25 million range and that while uncertified it would lose about $5 million-$10 million per quarter. They added Cedar Hill has been losing roughly $10 million a month and Palm Beach Gardens lost about $15 million this quarter but should gradually improve.
"When we first announced the loss of certification at Laurel Ridge, we disclosed that last year, the pre-tax income at that facility was in the $20 million-$25 million range." — Steve Filton (CFO)
Labor trends and Talkspace timing
Q (Matthew Gillmor · KeyBanc): The analyst asked for details on wage growth, turnover, and contract labor. He also asked whether Talkspace synergies will show up in 2027 or later.
A: Management said behavioral headcount growth has decelerated and aligned with volume (headcount rose about 1.5% in the quarter). In acute care, temporary and traveling labor has fallen and wage inflation is now about 3%-3.5% in both segments. On Talkspace, they said the deal should be slightly accretive in the first 12 months and most revenue synergies will emerge in the first 12-24 months, beginning in the back half of next year.
"our expectation in the first 12 months of ownership, which would be into the third quarter of next year, was that the transaction would be slightly accretive." — Steve Filton (CFO)
Revenue per admission pressure and geography
Q (Stephen Baxter · Wells Fargo): The analyst asked how to think about same-store acute revenue per adjusted admission excluding year-over-year Medicaid supplemental items and how much the surgical decline pressured that metric. He also asked about geographic or payer strengths behind acute volume improvement.
A: Management said three items pressured revenue per admission: exchanges, out-of-period DPP, and med-surg mix. They estimated med-surg mix reduced revenue per admission growth by about 100 basis points and that adjusting for all three items revenue per admission would have been up about 3%. They said acute volume strength was broad-based, with Medicare growing faster than the division average and Medicaid and commercial positive but slower; self-pay rose largely replacing exchange declines.
"We think the med surg mix pressure probably reduces the growth in revenue per adjusted admission by about 100 basis points." — Steve Filton (CFO)
Why surgical cases shifted faster
Q (Kevin Fischbeck · BofA): The analyst asked what is causing the recent acceleration of procedures shifting out of the hospital and how long that acceleration might last. He also asked to confirm the long-term growth algorithms.
A: Management said they do not think inpatient-only rule changes are the cause and pointed to a broader shift of procedures into physician offices and ASCs, using GI as an example where outpatient trends even limit ER coverage. They noted difficulty getting GI coverage for ERs. They restated growth algorithms: acute adjusted admission growth 1.5%-2.5% (about 2.6% this year) with 2%-3% pricing; behavioral adjusted patient day growth 1%-2% (running about 1.7% this year) with 2%-3% pricing.
"As a consequence, in some of our facilities, even our emergency room visits that are GI-related are being diverted to someplace else because we just do not have the coverage." — Steve Filton (CFO)
Talkspace performance and outpatient expansion
Q (Craig Hettenbach · Morgan Stanley): The analyst asked how Talkspace is performing and growth expectations, and how the combined offering affects payer relationships. He also asked about organic outpatient expansion and other tuck-ins.
A: Management said integration creates two-way referrals: UHS can send patients to Talkspace and Talkspace can refer patients needing higher care into UHS, and they are just starting to see that happen but cannot give exact numbers yet. They said Talkspace's team is encouraged and they are optimistic. On outpatient expansion they highlighted intensive outpatient and partial hospitalization expansion, Thousand Branches, and ongoing evaluation of tuck-in acquisitions.
"That opportunity now exists for us to send patients, refer patients over to Talkspace who are already in our ecosystem, whether in our outpatient settings or in our inpatient settings." — Marc Miller (CEO)
Behavioral EBITDA drag and Medicaid cuts
Q (Jason Cassorla · Guggenheim): The analyst asked why same-facility behavioral EBITDA was flat despite revenue growth and asked for more detail on the $10 million Medicaid supplemental headwind in Q4 2027 and updates on 2028 provider-tax headwinds.
A: Management said Laurel Ridge is likely the single biggest drag on behavioral earnings improvement and that pricing has moved into a 2%-3% range after earlier stronger years. On the $10 million Q4 2027 headwind, management did not have the detailed state-level breakout on the call and offered to discuss it offline; they said estimates for 2028 and beyond have been disclosed in SEC filings and will be updated.
"I think that Laurel Ridge is probably the single biggest drag on the behavioral earnings improvement." — Steve Filton (CFO)
Mix versus volume trade-off
Q (Andrew Mok · Barclays): The analyst asked whether management is comfortable trading mix and price for stronger volumes and whether this would change strategy.
A: Management said it was not a conscious trade to increase volumes while reducing procedural mix. They explained most medical volumes come through the emergency room and procedural volumes are more elective; they are investing in technology, OR capacity, and outpatient access points to grow procedures and aim to grow both overall volumes and surgical/procedural volumes.
"We're not making a choice of medical admissions over surgical admissions." — Steve Filton (CFO)
Post-ramp capital spending priorities
Q (Ben Hendrix · RBC): The analyst asked which development priorities will come first after de novo ramps and Talkspace integration—behavioral build-out, acute service lines, or tech and AI.
A: Management clarified the move from roughly $1 billion to $800 million in annual CapEx reflects no new full-scale de novos rather than pure maintenance. They said maintenance is nearer $250 million-$300 million and the remainder (about $400 million-$550 million) is expansionary capital for new beds, ORs, ERs, robotics, and outpatient access, with emphasis on outpatient growth in both segments.
"So there's another $400 million, $500 million, $550 million of expansionary capital in the $800 million." — Steve Filton (CFO)
SDP split and MA plan margins
Q (Scott Fidel · Goldman Sachs): The analyst asked to break the anticipated state-directed payment headwind between acute and behavioral. He also asked for an update on the Medicare Advantage plan margins and how they bid for 2027.
A: Management said SDP payments and reductions are split pretty evenly between the two segments. They described the health plan as about 90% MA and 10% commercial, said they saw roughly a $25 million improvement in 2026 from the plan, and that historically the plan has operated with either low negative single-digit margins or low positive single-digit margins; currently it is operating in low positive single-digit margins.
"We think that historically the plan has operated with either low negative single-digit margins or low positive single-digit margins." — Steve Filton (CFO)
Margin offset initiatives and timing
Q (Benjamin Rossi · JPMorgan): The analyst asked how payer mix initiatives, outpatient network growth, technology and expense actions are coming together and when they will contribute to margins.
A: Management said they are pursuing revenue-cycle improvements and technology and AI efforts to improve revenue cycle performance and to better control length of stay in acute care. They are expanding outpatient offerings in behavioral (Talkspace, Thousand Branches, and existing facilities) to shift payer mix away from Medicaid toward commercial and Medicare. They said they will provide more color when giving guidance in February.
"Technology developments, we have talked in previous quarterly calls about the things that we are doing in revenue cycle to improve revenue cycle performance." — Steve Filton (CFO)
Exchange assumption and Talkspace proof
Q (Sarah James · Cantor Fitzgerald): The analyst asked whether the $15 million exchange headwind assumes flat exchange market size from 2026 to 2027 and what proof points would show Talkspace step-down capture is working and its timeline.
A: Management confirmed the $15 million headwind is from annualizing the $50 million second-half 2026 run rate into next year and said further reductions could add to the headwind pending enrollment data. For Talkspace, they said proof will be accelerating outpatient visits at both UHS and Talkspace — UHS outpatient visits grew about 3% in Q3 and Talkspace grew about 5% — and they expect those rates to accelerate with integration, with limited impact in the first 12 months and more visible benefit beginning in the following 12 months.
"We're assuming that at a minimum, the $50 million is the run rate into next year." — Steve Filton (CFO)